FIELD: medicine; pharmacology.
SUBSTANCE: compositions under this invention are used as treatment or prevention agents for immune diseases including not steroid immunophylin-dependent immunosuppressant (NsIDI) and intensifier NsIDI (NsIDIE), chosen of selective serotonin recapture inhibitor (SSRI), tricyclic antidepressant (TCA), phenoxy phenol, antihistaminic agent, phenothiazine or mu-opioid receptor antagonist.
EFFECT: increased efficiency of immune disease treatment.
38 cl, 26 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS | 2012 |
|
RU2640912C2 |
| SUPERCRITICAL LIQUID EXTRACT CONTAINING CARDIAC GLYCOSIDE | 2006 |
|
RU2398591C2 |
| METHOD OF TREATING THERMOREGULATION DISORDER | 2007 |
|
RU2478379C2 |
| METHOD OF PROPHYLAXIS OF NEPHROTOXICITY INDUCED BY CYCLOSPORINE OR TACROLIMUS | 1998 |
|
RU2191020C2 |
| DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS | 2013 |
|
RU2719579C2 |
| DOSING MODES FOR ECHINOCANDINE CLASS COMPOUNDS | 2013 |
|
RU2639483C2 |
| TREATING PSYCHOLOGICAL CONDITIONS WITH USING M-MUSCARINIC ANTAGONISTS | 2007 |
|
RU2477634C2 |
| COMBINATIONS CONTAINING ALPHA-2-DELTA LIGANDS AND SEROTONIN/NORADRENALINE REUPTAKE INHIBITORS | 2004 |
|
RU2320369C2 |
| THE SELECTIVE INVERSE AGONISTS OF SEROTONIN RECEPTORS AS MEDICATION TO CURE DISEASES | 2005 |
|
RU2442607C2 |
| COMPOUND OF AVERMECTIN FAMILY OR OF MILBEMYCIN FAMILY FOR TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | 2014 |
|
RU2669942C1 |
